openPR Logo
Press release

Radiotherapy Market worth USD 9.3 Billion By 2024: Top Venders Like Varian Medical Systems, Elekta AB, Accuray, CIVCO Medical Solutions, Brainlab AG, RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems and Others

Radiotherapy Market worth USD 9.3 Billion By 2024: Top Venders

Radiotherapy Market report provides an Industry overview of the its characteristics, market size and growth, industry segmentation, market shares, trends and Key player strategies, industry chain structure, development history & status, competitive landscape analysis.

New research report of Global radiotherapy market is predictable to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Beam radiotherapy market has the largest market segment in radiotherapy market.

To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market

Global Radiotherapy Market Drivers:

Some of the major factors driving theradiotherapy market are rising incidence of cancer, increasing acceptance of adaptive radiation therapy (ART), growing pool of geriatric population and increasing number of cancer treatment facilities. Also,increase in out-patient cancer facilities, increasing demand for better radiotherapy equipments, replacement of out dated products and increasing influx of government and private funding for radiotherapy technology are driving the growth of the radiotherapy market.

GROWING PREVALENCE OF CANCER

In recent years, the prevalence of cancer across the globe has increased considerably over a period of time. The rapidly increasing prevalence of cancer and the subsequent rise in chronic conditions are major factors driving the demand radiotherapy devices.

RISING AGING POPULATION

With increasing age, the patient pool for chronic disease is rising which includes the growth of cancer cases among the older population. Since, cancer incidence is increasing exponentially with advancing age, it is expected to affect the older population which will impact the growth of the older cancer patient pool.

Elekta AB:

Founded in 1972 and headquartered in Stockholm, Sweden by Lars Leksell and Laurent Leksell. Elekta is a provider of human care, which specialises in the treatment of cancers and brain disorders. It provides oncologists, radiation therapists, neurosurgeons, and other medical specialists with the aid of clinical solutions and tools.

Have Any Query? Inquire here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market

TABLE OF CONTENTS GLOBAL RADIOTHERAPY MARKET

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL RADIOTHERAPY MARKET
1.1.1. CURRENCY AND PRICING
1.1.2. LIMITATION
1.1.3. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. GROWING PREVALENCE OF CANCER
3.1.2. RISING AGEING POPULATION
3.1.3. UNHEALTHY LIFESTYLE
3.1.4. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS

3.2. RESTRAINTS

3.2.1. REGULATORY SCENARIO
3.2.2. HIGH COST OF RADIOTHERAPY

3.3. OPPORTUNITIES

3.3.1. GROWING MEDICAL TOURISM IN ASIA
3.3.2. EMERGING MARKET

3.4. CHALLENGES

3.4.1. SIDE-EFFECTS OF RADIOTHERAPY
3.4.2. REQUIREMENT OF TRAINED STAFF

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE

6.1. OVERVIEW
6.2. BEAM RADIOTHERAPY, BY THERAPY TYPE
6.3. BRACHYTHERAPY, BY THERAPY TYPE

7. GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE

7.1. OVERVIEW
7.2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.3. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.4. GLOBAL RADIOTHERAPY SOFTWARES MARKET, BY PRODUCT TYPE

8. GLOBAL RADIOTHERAPY MARKET, BY INDICATION

8.1. OVERVIEW

9. GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.2. NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.2.1. U.S. RADIOTHERAPY MARKET
9.2.2. CANADA RADIOTHERAPY MARKET
9.2.3. MEXICO RADIOTHERAPY MARKET

9.3. EUROPE RADIOTHERAPY MARKET

9.3.1. GERMANY RADIOTHERAPY MARKET
9.3.2. FRANCE RADIOTHERAPY MARKET
9.3.3. U.K. RADIOTHERAPY MARKET
9.3.4. SWITZERLAND RADIOTHERAPY MARKET
9.3.5. ITALY RADIOTHERAPY MARKET
9.3.6. RUSSIA RADIOTHERAPY MARKET
9.3.7. NETHERLANDS RADIOTHERAPY MARKET
9.3.8. SPAIN RADIOTHERAPY MARKET
9.3.9. BELGIUM RADIOTHERAPY MARKET
9.3.10. TURKEY RADIOTHERAPY MARKET

9.4. APAC RADIOTHERAPY MARKET SNAPSHOT: 2016

9.4.1. JAPAN RADIOTHERAPY MARKET
9.4.2. CHINA RADIOTHERAPY MARKET
9.4.3. INDIA RADIOTHERAPY MARKET
9.4.4. SOUTH KOREA RADIOTHERAPY MARKET
9.4.5. AUSTRALIA RADIOTHERAPY MARKET
9.4.6. THAILAND RADIOTHERAPY MARKET
9.4.7. MALAYSIA RADIOTHERAPY MARKET
9.4.8. INDONESIA RADIOTHERAPY MARKET
9.4.9. SINGAPORERADIOTHERAPY MARKET
9.4.10. PHILIPPINES RADIOTHERAPY MARKET

9.5. SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.5.1. BRAZIL RADIOTHERAPY MARKET

9.6. MEA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.6.1. SAUDI ARABIA RADIOTHERAPY MARKET

10. GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE

10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

11. COMPANY PROFILES

11.1. VARIAN MEDICAL SYSTEMS, INC.

11.1.1. COMPANY OVERVIEW

11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.1.3. DRIVERS EXPLAINED

11.1.3.1. DIVERSE PRODUCT PORTFOLIO:
11.1.3.2. STRONG RESEARCH AND DEVELOPMENT CAPABILITIES:

11.1.4. WEAKNESSES EXPLAINED

11.1.4.1. DEPENDENCE ON LIMITED NUMBER OF SUPPLIERS:

11.1.5. OPPURTUNITIES EXPLAINED

11.1.5.1. VARIAN COULD EXPAND ITS POSITION WITH IMAGING COMPONENTS BUSINESS’ SPIN-OFF:
11.1.5.2. ACQUISITIONS LIKELY TO ENHANCE VARIAN’S ONCOLOGY AND IMAGING BUSINESSES:
11.1.5.3. EXPANSION IN OPERATIONS IN THE U.S.:
11.1.5.4. INCREASING INCIDENCE OF CANCER TO DRIVE GLOBAL RADIATION THERAPY EQUIPMENT MARKET:

11.1.6. THREATS EXPLAINED

11.1.6.1. INTENSE COMPETITION COULD AFFECT VARIAN’S MARKET SHARE AND RESULTS OF OPERATION:
11.1.6.2. INCREASING MEDICAL COSTS IN CANCER TREATMENT AND CARE: 259

11.1.7. REVENUE ANALYSIS

11.1.8. PRODUCT PORTFOLIO

11.1.9. RECENT DEVELOPMENTS

11.1.10. DATA BRIDGE ANALYSIS

11.2. ELEKTA AB

11.2.1. COMPANY OVERVIEW
11.2.2. REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATA BRIDGE ANALYSIS

11.3. NANOBIOTIX

11.3.1. COMPANY OVERVIEW
11.3.2. REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATA BRIDGE ANALYSIS

11.4. ACCURAY, INC.

11.4.1. COMPANY OVERVIEW
11.4.2. REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPMENTS

11.5. BRAINLAB AG

11.5.1. COMPANY OVERVIEW

11.5.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.5.3. DRIVERS EXPLAINED

11.5.3.1. STRONG PARTNER NETWORK:
11.5.3.2. ESTABLISHED PRESENCE IN MARKETS:

11.5.4. WEAKNESSES EXPLAINED

11.5.4.1. PRODUCT SAFETY CONCERNS:

11.5.5. OPPURTUNITIES EXPLAINED

11.5.5.1. STRATEGIC INITIATIVES:

11.5.6. THREATS EXPLAINED

11.5.6.1. RAPID TECHNOLOGICAL CHANGES:
11.5.6.2. STRINGENT GOVERNMENT REGULATIONS:

11.5.7. REVENUE ANALYSIS

11.5.8. PRODUCT PORTFOLIO

11.5.9. RECENT DEVELOPMENTS

11.6. ION BEAM APPLICATIONS SA

11.6.1. COMPANY OVERVIEW
11.6.2. REVENUE ANALYSIS
11.6.3. PRODUCT PORTFOLIO
11.6.4. RECENT DEVELOPMENTS

11.7. MEVION MEDICAL SYSTEMS, INC.

11.7.1. COMPANY OVERVIEW
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. RECENT DEVELOPMENTS

11.8. ISORAY MEDICAL, INC.

11.8.1. COMPANY OVERVIEW
11.8.2. REVENUE ANALYSIS
11.8.3. PRODUCT PORTFOLIO
11.8.4. RECENT DEVELOPMENTS

11.9. NORDION (CANADA) INC.

11.9.1. COMPANY OVERVIEW

11.9.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.9.3. DRIVERS EXPLAINED

11.9.3.1. ESTABLISHED PRESENCE IN GAMMA IRRADIATION INDUSTRY:

11.9.4. WEAKNESSES EXPLAINED

11.9.4.1. RADIATION EXPOSURE CLAIMS AND OTHER DISPUTES:

11.9.5. OPPURTUNITIES EXPLAINED

11.9.5.1. STRATEGIC INITIATIVES:

11.9.6. THREATS EXPLAINED

11.9.6.1. RAPID TECHNOLOGICAL CHANGES:
11.9.6.2. STRINGENT GOVERNMENT REGULATIONS:
11.9.6.3. STIFF COMPETITION:

11.9.7. REVENUE ANALYSIS

11.9.8. PRODUCT PORTFOLIO

11.9.9. RECENT DEVELOPMENTS

11.10. RAYSEARCH LABORATORIES AB

11.10.1. COMPANY OVERVIEW
11.10.2. REVENUE ANALYSIS
11.10.3. PRODUCT PORTFOLIO
11.10.4. RECENT DEVELOPMENTS

11.11. PRECISIS AG

11.11.1. COMPANY OVERVIEW
11.11.2. REVENUE ANALYSIS
11.11.3. PRODUCT PORTFOLIO
11.11.4. RECENT DEVELOPMENTS

12. RELATED REPORTS

Read more about the Global Radiotherapy Market Landscape: http://databridgemarketresearch.com/reports/global-radiotherapy-market/

Related Report

Europe Radiotherapy Market – Industry Trends and Forecast to 2024

Europe Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/europe-radiotherapy-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiotherapy Market worth USD 9.3 Billion By 2024: Top Venders Like Varian Medical Systems, Elekta AB, Accuray, CIVCO Medical Solutions, Brainlab AG, RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems and Others here

News-ID: 1108429 • Views:

More Releases from Data Bridge Market Research

Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 to 2030
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness. Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies and Competitive Landscape Top Players Analysis Industry Trends and Forecast
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into

All 5 Releases


More Releases for THERAPY

Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023. The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market. Factors that are likely to hamper the growth of the market